Cergutuzumab amunaleukin (Synonyms: CEA-IL2v; RG 7813; RO 6895882) |
| Catalog No.GC68854 |
Cergutuzumab amunaleukin (CEA-IL2v) is an immune cytokine based on a variant of IL-2 targeted to carcinoembryonic antigen (CEA). Cergutuzumab amunaleukin has immunostimulatory and anti-tumor activity.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1509916-03-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Cergutuzumab amunaleukin
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Cergutuzumab amunaleukin
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *